Share/Refer CSATC

Doctor Administers medical Marijuana

Keeping You Informed

CSATC - New Jersey Medical Marijuana Dispensary

News

Administering Medical Cannabis

Vaporizing or smoking cannabis is a popular way for patients to ingest medicine. Some patients find that ingesting cannabis in different ways other than vaporizing or smoking suits their needs and improves their symptoms best. Compassionate Sciences™ ATC offers alternative methods of administration to patients in a topical and sublingual form, as well as providing patients with detailed instructions on how to make cannabis infused edibles with CSATC extracts and other products. CSATC carries Lozenges, which allow patients to sublingually ingest cannabis. Our Topical Oil can be added to other essential oils and applied topically for localized relief. We also carry cannabis infused Cocoa Butter that can be applied topically or used as a butter alternative in cooking recipes.
 
 
For patients who want to make their own cannabis infused foods or treats, CSATC provides high quality cannabis flower or vape mix that patients can infuse into their desired food. In addition, CSATC carries a recipe book that patients are encouraged to look through to find a recipe that fits their needs.

Posted on in category: Products | Tagged | Comments Off on Administering Medical Cannabis

New Strain Announcement

Compassionate Sciences™ ATC is growing seven new strains, Blueberry being one of them. Another strain that will be released before 2018 is Cookie Wreck, a hybrid cross of Girl Scout Cookies and Train Wreck. This hybrid strain delivers a powerful cerebral euphoria and heavy full body effects that Leafly says works well for pain, stress, muscle spasms, nausea and headaches. We will announce the release dates for Cookie Wreck and Blueberry as they approach. Stay tuned for announcements about the other five strains CSATC is growing.

Posted on in category: Dispensary News | Comments Off on New Strain Announcement

Double Strain Highlight: Albert’s Super Silver Sour Diesel & Super Lemon Haze

Albert’s Super Silver Sour Diesel

At Compassionate Sciences™, we provide a sativa dominant Albert’s Super Silver Sour Diesel strain that produces cerebral effects with an undertone of relaxation that patients say works great for muscle tension, joint pain, arthritis and nerve pain.

A distinct cross of the strain Skunk, Silver Haze and Sour Diesel, new patients should medicate cautiously with this potent strain. Albert’s Super Silver Sour Diesel is a great morning and day time strain for patients who are searching for pain relief without the full body effects of an indica dominant strain.
Super Lemon Haze

CSATC also provides a sativa dominant Super Lemon Haze strain that exhibits energetic, focused, happy and uplifted effects that patients say works well for chronic pain, stress, depression, fatigue and more.

A cross of the three-time Cannabis Cup winner Super Silver Haze and Lemon Skunk, Super Lemon Haze lives up to its name with its lemon, citrus, sweet and earthy scents. With its specific full spectrum cannabinoid profile and the terpenes linalool and limonene, patients find this strain to be helpful during the morning and for daytime use, keeping them clear-headed and energized.

Posted on in category: Strain Highlight | Tagged | Comments Off on Double Strain Highlight: Albert’s Super Silver Sour Diesel & Super Lemon Haze

Qualifying Condition: Posttraumatic Stress Disorder

Posttraumatic stress disorder is the most recent addition to the list of qualifying conditions for the New Jersey Medical Marijuana Program. PTSD is an anxiety disorder that is triggered by an extremely disturbing or mentally stressful event. This disorder can develop after a person witnessed or experienced a traumatic event that includes a threat of harm or actual physical harm. Traumatic events that can cause PTSD include sexual or physical assault, an unexpected death, an accident, war or natural disasters. Many people who experience traumatic events will have reactions such as anger, fear, guilt, nervousness and shock. For most people, these feelings will decrease and go away over time. However, those who have PTSD will experience these effects, possibly in an increasing manner, for longer than one month. As a result of experiencing these prolonged effects, patients with PTSD see a decreased quality of life compared to before the event.
 
 

“A study of Medical Marijuana patients in New Mexico
found more than a 75 percent reduction in the Clinician Administered Posttraumatic Scale symptom scores
when the patients
were using cannabis compared
to when they were not….”

 
 
The symptoms of PTSD are grouped into four categories. First, reliving is when patients relive the thoughts and memories of the trauma. This category can include flashbacks, hallucinations and nightmares that can occur out of nowhere or when triggered by a reminder such as an anniversary date of the event. Second, avoiding is when patients avoid people, places or situations that remind them of the trauma. Avoidance can lead to detachment or isolation from loved ones, as well as a loss of interest in activates that one used to enjoy. Third, increased arousal includes patients having excessive emotions, problems feeling or showing emotions, difficulty sleeping or concentrating, irritability, bursts of anger and being jumpy. Lastly, patients may experience negative cognitions and moods, referring to thoughts and feelings of blame, estrangement and memories of the traumatic event.

PTSD is often treated with antidepressant medications, which may carry detrimental side effects, or different forms of psychotherapy. Our patients have reported many positive effects using indica dominant strains such as Blackberry Kush and Hindu Kush for PTSD, and a study of Medical Marijuana patients in New Mexico found more than a 75 percent reduction in the Clinician Administered Posttraumatic Scale symptom scores when the patients were using cannabis compared to when they were not.

Posted on in category: Qualifying Conditions | Tagged , , | Comments Off on Qualifying Condition: Posttraumatic Stress Disorder

CSATC Advocates for Patients

CSATC is constantly advocating for improvements to be made in the regulations of the New Jersey Medical Marijuana Program. Our main points of advocacy are towards increasing accessibility and affordability for patients that use medical cannabis, as well as improving regulations to give patients more timely product information.

To improve accessibility, we are urging legislators and regulators to allow home deliveries of medical cannabis. We are also stressing the importance of adding qualifying conditions, such as chronic pain related to musculoskeletal disorders, migraines, anxiety, chronic pain of visceral origin and Tourette’s Syndrome, which are supported by scientific evidence and have went through public comment and review periods required by the MMP. To further help patients that are already suffering with debilitating medical conditions, we are advocating for the removal of the requirement for registry of physicians, allowing all physicians and nurses in good standing to recommend medical cannabis to qualifying patients.

To improve affordability, we are urging the state to remove its monetary requirements to join the program such as patient registration fees, the 90-day renewal requirement and removing the tax on sales of medical cannabis. We are advocating that patients should have differentiated cost and preference in the cannabis market if adult-use legislation is enacted. To further lessen the economic burden on patients, we believe that the legislation should encourage insurance company coverage of MMJ.

To give patients more timely product information, CSATC is advocating for more routine and more frequent testing for MMP products. In order to handle the increased demand of testing, we have suggested immediately issuing licenses for private testing labs and to allow in-house testing. To ensure equal testing standards and practices, all cannabis products should be tested by an accredited lab that is held to national standards. Labs should test for potency, solvents, microbiological contaminants, water activity/moisture content and pesticides.

 

Posted on in category: New Jersey News, Dispensary News | Tagged , , , | Comments Off on CSATC Advocates for Patients

Silvertip Silver Dollar Pancakes

(Sensitive Stomach Friendly Gluten Free Pancakes)
 
Silvertip is a high CBG strain, meaning it can be beneficial for any range of gastrointestinal symptoms. Not only is this recipe gluten free, but it can also be great for days when your stomach is acting up.
 
Ingredients:
1 Banana
1 Egg
1 Tbs Cannabutter/Cannaoil
 
Directions:
Mash banana in medium bowl.
Whisk in egg.
Put one tablespoon of cannabis butter/oil in your skillet over medium heat.
Once melted, pour in pancake batter to desired size and flip once you see bubbles forming on the top of the pancake.
Flip and keep on stove about four minutes.
Add butter/oil as needed!
 
 

Posted on in category: Patient Recipes | Comments Off on Silvertip Silver Dollar Pancakes

Six New Strains Coming Soon

CSATC is growing six new strains that should be released by the end of the 2017. Patients find our assortment of “blue” strains to be useful in combatting many symptoms they experience. Blue Dream, Blueberry Silvertip, Blue Tahoe and Blue Widow 1 are all hybrids of the High Times’ Cannabis Cup 2000 Best Indica strain, Blueberry, which is one of the six new strains that CSATC is cultivating. Blueberry’s lineage is most often traced to the American breeder DJ Short, who created the strain when working with a variety of exotic landrace strains. According to Leafly, Blueberry is helpful for stress, pain, depression, insomnia and headaches. We expect Blueberry to be available for purchase this fall.
 

Patients find our assortment of “blue” strains
to be useful in combatting many symptoms they experience….

 
Stay tuned for future announcements about our other five strains!

Posted on in category: Dispensary News, Products, Strain Highlight | Comments Off on Six New Strains Coming Soon

Scientific Focus: The Endocannabinoid System

Did you know that you have an endocannabinoid system?


The endocannabinoid system was initially discovered in the late 1980s when scientist studied how THC and other cannabinoids interact. Cannabis can function efficiently in mammal’s due to a series of receptors in the pathways of the brain called the endocannabinoid system (ECS).

 

Cannabinoids bind with the endocannabinoid
receptors, creating medical effects
by suppressing signals
such as pain, nausea and depression
while boosting appetite and euphoria.

 

It was discovered that humans are designed to interact with cannabinoids through the ECS which consist of CB1 and CB2 receptors. Cannabinoids and terpenes are delivered to the bloodstream either through the lungs (when inhaled), the digestive system (when consumed) or the skin (when applied topically). From the blood stream, cannabinoids become available to the central nervous system through the CB1 receptors and the immune system through CB2 receptors.

These receptors influence the flow of chemical signals to the brain and digestive system. Cannabinoids bind with the endocannabinoid receptors, creating medical effects by suppressing signals such as pain, nausea and depression while boosting appetite and euphoria. Cannabis use effects the neurotransmitter GABA by blocking it. The result is increasing dopamine levels which GABA normally inhibits or regulates. Dopamine offers a mood shift of reward for the brain that is released with sex, exercise, appetite, learning, sleep, movement and mood.

 
Cannabis effects the cannabinoid receptors, namely CB1 and CB2 that mimic a naturally created endogenous molecule, anandamide. Anandamide is an Omega 6 fatty acid that regulates appetite, cognition, emotion, memory, mood and pain. Delta-9-tetrahydrocannabinol (THC) and other cannabinoids found in cannabis can affect anandamide and therefore effect the endocannabinoid central nervous system.

 
The most exciting and promising lines of research into the role of the endocannabinoid system is in the regulation of inflammation and the immune system. Clinical evidence has shown the effectiveness of endocannabinoids on treating epilepsy, multiple sclerosis, muscle spasms and other neuromuscular system disorders.

Posted on in category: Science, Qualifying Conditions, Research | Tagged , , , | Comments Off on Scientific Focus: The Endocannabinoid System

More Products & Advanced Formulation Brings New Potency to CSATC’s Extractions

New Extract Products To Come
CSATC is involved in constant research and development and recently we have made headway in improving our extracted product selection. CSATC, the only alternative treatment center in the state that offers non-smoking forms of cannabis, currently produces extracted products in the form of Cocoa Butter Lotion, Lozenges and Topical Oil. We will continue to produce the current formulation for our products that consists of a 10:1 THC to CBD ratio, but we are working on an advanced formulation that will have a 1:1 THC to CBD ratio. In addition to our new formulation, we developed three new extract products that will be sent to the state shortly for approval. You can expect announcements about the products once they are approved.

…We are working on a formulation
that will have a 1:1 THC to CBD ratio….

 

 

Posted on in category: Research, Dispensary News, Products | Tagged | Comments Off on More Products & Advanced Formulation Brings New Potency to CSATC’s Extractions

Strain Highlight: Agent Orange & Wappa

At Compassionate Sciences™, we provide a (50×50) hybrid Agent Orange strain, which produces happy, energetic and euphoric effects that patients say works best for stress, depression, chronic pain, fatigue, nausea, anxiety, arthritis, cancer, migraines, PMS and PTSD.
 
This dynamic cannabis strain is a result of crossing Jack the Ripper and Orange Velvet. Many patients find this strain to be more uplifting than sedative. With its refreshing aroma of sweetness, citrus and oranges, patients find Agent Orange to be a great mood enhancer for use throughout their day.

Terpenes – Limonene, Myrcene
Scents – Citrus, Orange, Sweet
Effects – Happy, Energetic, Euphoric, Relaxed, Uplifted, Focused

 
 

CSATC also provides an indica dominant Wappa strain that exhibits relaxed, happy and uplifted effects that patients say works great for chronic pain, insomnia, anxiety, stress, depression and headaches.
 
This potent indica-dominant hybrid has lineage from the Skunk strain, and was bred through selecting the “juiciest” plants of each generation to build the distinct Wappa profile. Despite its indica dominance, patients find this strain helpful for both daytime and nighttime use with minimal “couch lock” effects. Patients report uplifting effects as well as a body buzz that reflects its indica dominance.

Terpenes – Myrcene, Caryophyllene
Scents – Sweet, Earthy, Pungent

Effects
– Relaxed, Happy, Uplifted, Focused
 

Posted on in category: Strain Highlight | Comments Off on Strain Highlight: Agent Orange & Wappa
Top